Stock Events

Stock Events

Eucrates Biomedical Acquisition 

$10.04
4
+$0+0% Wednesday 21:14

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
135.13M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q3 2020
Q4 2020
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.01
0.04
0.1
0.15
Expected EPS
N/A
Actual EPS
0.04

Financials

-Profit Margin
Profitable
2020
2021
2022
0Revenue
2.42MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EUCR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
Show more...
CEO
Country
VG
ISIN
VGG3141W1068

Listings

0 Comments

Share your thoughts

FAQ

What is Eucrates Biomedical Acquisition stock price today?▼
The current price of EUCR is $10.04 USD — it has increased by +0% in the past 24 hours. Watch Eucrates Biomedical Acquisition stock price performance more closely on the chart.
What is Eucrates Biomedical Acquisition stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Eucrates Biomedical Acquisition stocks are traded under the ticker EUCR.
What is Eucrates Biomedical Acquisition market cap?▼
Today Eucrates Biomedical Acquisition has the market capitalization of 135.13M
What were Eucrates Biomedical Acquisition earnings last quarter?▼
EUCR earnings for the last quarter are 0.04 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Eucrates Biomedical Acquisition revenue for the last year?▼
Eucrates Biomedical Acquisition revenue for the last year amounts to 0 USD.
What is Eucrates Biomedical Acquisition net income for the last year?▼
EUCR net income for the last year is 2.42M USD.
In which sector is Eucrates Biomedical Acquisition located?▼
Eucrates Biomedical Acquisition operates in the Other sector.
When did Eucrates Biomedical Acquisition complete a stock split?▼
Eucrates Biomedical Acquisition has not had any recent stock splits.